Year |
Citation |
Score |
2018 |
Chao J, Guo Y, Chao L. Protective Role of Endogenous Kallistatin in Vascular Injury and Senescence by Inhibiting Oxidative Stress and Inflammation. Oxidative Medicine and Cellular Longevity. 2018: 4138560. PMID 30622668 DOI: 10.1155/2018/4138560 |
0.393 |
|
2018 |
Yao Y, Li B, Liu C, Fu C, Li P, Guo Y, Ma G, Liu N, Chao L, Chao J. Reduced Plasma Kallistatin Is Associated With the Severity of Coronary Artery Disease, and Kallistatin Treatment Attenuates Atherosclerotic Plaque Formation in Mice. Journal of the American Heart Association. 7: e009562. PMID 30554563 DOI: 10.1161/Jaha.118.009562 |
0.353 |
|
2018 |
Guo Y, Chao L, Chao J. Kallistatin attenuates endothelial senescence by modulating Let-7g-mediated miR-34a-SIRT1-eNOS pathway. Journal of Cellular and Molecular Medicine. PMID 29992759 DOI: 10.1111/Jcmm.13734 |
0.355 |
|
2017 |
Chao J, Guo Y, Li P, Chao L. Opposing Effects of Oxygen Regulation on Kallistatin Expression: Kallistatin as a Novel Mediator of Oxygen-Induced HIF-1-eNOS-NO Pathway. Oxidative Medicine and Cellular Longevity. 2017: 5262958. PMID 29387292 DOI: 10.1155/2017/5262958 |
0.36 |
|
2017 |
Chao J, Guo Y, Li P, Chao L. Role of Kallistatin Treatment in Aging and Cancer by Modulating miR-34a and miR-21 Expression. Oxidative Medicine and Cellular Longevity. 2017: 5025610. PMID 28744338 DOI: 10.1155/2017/5025610 |
0.316 |
|
2017 |
Chao J, Li P, Chao L. Kallistatin: double-edged role in angiogenesis, apoptosis and oxidative stress. Biological Chemistry. PMID 28742513 DOI: 10.1515/Hsz-2017-0180 |
0.386 |
|
2017 |
Guo Y, Li P, Gao L, Zhang J, Yang Z, Bledsoe G, Chang E, Chao L, Chao J. Kallistatin reduces vascular senescence and aging by regulating microRNA-34a-SIRT1 pathway. Aging Cell. PMID 28544111 DOI: 10.1111/Acel.12615 |
0.734 |
|
2017 |
Chao J, Li P, Chao L. Kallistatin suppresses cancer development by multi-factorial actions. Critical Reviews in Oncology/Hematology. 113: 71-78. PMID 28427524 DOI: 10.1016/J.Critrevonc.2017.03.011 |
0.346 |
|
2016 |
Chao J, Bledsoe G, Chao L. Protective Role of Kallistatin in Vascular and Organ Injury. Hypertension. PMID 27432868 DOI: 10.1161/Hypertensionaha.116.07861 |
0.777 |
|
2016 |
Zhang Q, Lee CS, Chao J, Chen CL, Zhang T, Sharma U, Zhang A, Liu J, Rezaei K, Pepple KL, Munsen R, Kinyoun J, Johnstone M, Van Gelder RN, Wang RK. Wide-field optical coherence tomography based microangiography for retinal imaging. Scientific Reports. 6: 22017. PMID 26912261 DOI: 10.1038/Srep22017 |
0.569 |
|
2016 |
Li P, Guo Y, Bledsoe G, Yang Z, Chao L, Chao J. Kallistatin Induces Breast Cancer Cell Apoptosis and Autophagy by Modulating Wnt Signaling and microRNA Synthesis. Experimental Cell Research. PMID 26790955 DOI: 10.1016/J.Yexcr.2016.01.004 |
0.724 |
|
2015 |
Wang Y, Chen CL, Pan QZ, Wu YY, Zhao JJ, Jiang SS, Chao J, Zhang XF, Zhang HX, Zhou ZQ, Tang Y, Huang XQ, Zhang JH, Xia JC. Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma. Oncotarget. PMID 26575170 DOI: 10.18632/oncotarget.6319 |
0.588 |
|
2015 |
Zhang XF, Chao J, Pan QZ, Pan K, Weng DS, Wang QJ, Zhao JJ, He J, Liu Q, Jiang SS, Chen CL, Zhang HX, Xia JC. Overexpression of WWP1 Promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma. Oncotarget. PMID 26506518 DOI: 10.18632/oncotarget.5712 |
0.592 |
|
2015 |
Zhu T, Yao Q, Hu X, Chen C, Yao H, Chao J. The Role of MCPIP1 in Ischemia/Reperfusion Injury-Induced HUVEC Migration and Apoptosis. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 37: 577-591. PMID 26329288 DOI: 10.1159/000430378 |
0.642 |
|
2015 |
Lin WC, Chen CW, Huang YW, Chao L, Chao J, Lin YS, Lin CF. Kallistatin protects against sepsis-related acute lung injury via inhibiting inflammation and apoptosis. Scientific Reports. 5: 12463. PMID 26198099 DOI: 10.1038/Srep12463 |
0.681 |
|
2015 |
Guo Y, Li P, Bledsoe G, Yang ZR, Chao L, Chao J. Kallistatin inhibits TGF-β-induced endothelial-mesenchymal transition by differential regulation of microRNA-21 and eNOS expression. Experimental Cell Research. 337: 103-10. PMID 26156753 DOI: 10.1016/J.Yexcr.2015.06.021 |
0.74 |
|
2015 |
Li P, Guo Y, Bledsoe G, Yang ZR, Fan H, Chao L, Chao J. Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsis. Critical Care (London, England). 19: 200. PMID 25930108 DOI: 10.1186/S13054-015-0919-4 |
0.72 |
|
2015 |
Hsieh YH, Liu KK, Sulake RS, Chao JI, Chen C. Microwave-assisted efficient conjugation of nanodiamond and paclitaxel. Bioorganic & Medicinal Chemistry Letters. 25: 2074-7. PMID 25890802 DOI: 10.1016/j.bmcl.2015.03.089 |
0.57 |
|
2015 |
Cheng WC, Chung IF, Tsai CF, Huang TS, Chen CY, Wang SC, Chang TY, Sun HJ, Chao JY, Cheng CC, Wu CW, Wang HW. YM500v2: a small RNA sequencing (smRNA-seq) database for human cancer miRNome research. Nucleic Acids Research. 43: D862-7. PMID 25398902 DOI: 10.1093/Nar/Gku1156 |
0.576 |
|
2014 |
Yin KH, Hsieh YH, Sulake RS, Wang SP, Chao JI, Chen C. Optimization of gefitinib analogues with potent anticancer activity. Bioorganic & Medicinal Chemistry Letters. 24: 5247-50. PMID 25305687 DOI: 10.1016/j.bmcl.2014.09.056 |
0.591 |
|
2014 |
Chao J, Bledsoe G, Chao L. Kallikrein-kinin in stem cell therapy. World Journal of Stem Cells. 6: 448-57. PMID 25258666 DOI: 10.4252/Wjsc.V6.I4.448 |
0.755 |
|
2014 |
Gao L, Li P, Zhang J, Hagiwara M, Shen B, Bledsoe G, Chang E, Chao L, Chao J. Novel role of kallistatin in vascular repair by promoting mobility, viability, and function of endothelial progenitor cells. Journal of the American Heart Association. 3: e001194. PMID 25237049 DOI: 10.1161/Jaha.114.001194 |
0.739 |
|
2014 |
Chao J, Bledsoe G, Chao L. Tissue kallikrein-kinin therapy in hypertension and organ damage. Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progrã¨S Des Recherches Pharmaceutiques. 69: 37-57. PMID 25130039 DOI: 10.1007/978-3-319-06683-7_3 |
0.766 |
|
2014 |
Li P, Bledsoe G, Yang ZR, Fan H, Chao L, Chao J. Human kallistatin administration reduces organ injury and improves survival in a mouse model of polymicrobial sepsis. Immunology. 142: 216-26. PMID 24467264 DOI: 10.1111/Imm.12242 |
0.769 |
|
2013 |
Yang CR, Liao WS, Wu YH, Murugan K, Chen C, Chao JI. CR108, a novel vitamin K3 derivative induces apoptosis and breast tumor inhibition by reactive oxygen species and mitochondrial dysfunction. Toxicology and Applied Pharmacology. 273: 611-22. PMID 24128853 DOI: 10.1016/j.taap.2013.10.007 |
0.615 |
|
2013 |
Gao L, Bledsoe G, Yin H, Shen B, Chao L, Chao J. Tissue kallikrein-modified mesenchymal stem cells provide enhanced protection against ischemic cardiac injury after myocardial infarction. Circulation Journal : Official Journal of the Japanese Circulation Society. 77: 2134-44. PMID 23697984 DOI: 10.1253/Circj.Cj-12-1585 |
0.717 |
|
2013 |
Zhang J, Yang Z, Li P, Bledsoe G, Chao L, Chao J. Kallistatin antagonizes Wnt/β-catenin signaling and cancer cell motility via binding to low-density lipoprotein receptor-related protein 6. Molecular and Cellular Biochemistry. 379: 295-301. PMID 23666756 DOI: 10.1007/S11010-013-1654-2 |
0.732 |
|
2013 |
Yao Y, Sheng Z, Li Y, Fu C, Ma G, Liu N, Chao J, Chao L. Tissue kallikrein-modified human endothelial progenitor cell implantation improves cardiac function via enhanced activation of akt and increased angiogenesis. Laboratory Investigation; a Journal of Technical Methods and Pathology. 93: 577-91. PMID 23508045 DOI: 10.1038/Labinvest.2013.48 |
0.37 |
|
2013 |
Lin WC, Lu SL, Lin CF, Chen CW, Chao L, Chao J, Lin YS. Plasma kallistatin levels in patients with severe community-acquired pneumonia. Critical Care (London, England). 17: R27. PMID 23394256 DOI: 10.1186/Cc12507 |
0.626 |
|
2012 |
Liu Y, Bledsoe G, Hagiwara M, Shen B, Chao L, Chao J. Depletion of endogenous kallistatin exacerbates renal and cardiovascular oxidative stress, inflammation, and organ remodeling. American Journal of Physiology. Renal Physiology. 303: F1230-8. PMID 22811485 DOI: 10.1152/Ajprenal.00257.2012 |
0.778 |
|
2012 |
Patel AB, Chao J, Palmer LG. Tissue kallikrein activation of the epithelial Na channel. American Journal of Physiology. Renal Physiology. 303: F540-50. PMID 22622459 DOI: 10.1152/Ajprenal.00133.2012 |
0.359 |
|
2012 |
Tseng HH, Chuah QY, Yang PM, Chen CT, Chao JC, Lin MD, Chiu SJ. Securin enhances the anti-cancer effects of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075) in human colorectal cancer cells. Plos One. 7: e36006. PMID 22563433 DOI: 10.1371/journal.pone.0036006 |
0.635 |
|
2012 |
Cheng CW, Wang HW, Chang CW, Chu HW, Chen CY, Yu JC, Chao JI, Liu HF, Ding SL, Shen CY. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer. Breast Cancer Research and Treatment. 134: 1081-93. PMID 22476851 DOI: 10.1007/s10549-012-2034-4 |
0.599 |
|
2012 |
Yao Y, Sheng Z, Li Y, Yan F, Fu C, Li Y, Ma G, Liu N, Chao J, Chao L. Tissue kallikrein promotes cardiac neovascularization by enhancing endothelial progenitor cell functional capacity. Human Gene Therapy. 23: 859-70. PMID 22435954 DOI: 10.1089/Hum.2011.123 |
0.423 |
|
2012 |
Leung TK, Chen CH, Lai CH, Lee CM, Chen CC, Yang JC, Chen KC, Chao JS. Bone and joint protection ability of ceramic material with biological effects. The Chinese Journal of Physiology. 55: 47-54. PMID 22242954 DOI: 10.4077/CJP.2012.AMM113 |
0.627 |
|
2012 |
Leung TK, Huang PJ, Sun LM, Chu JS, Chen CS, Lee CM, Wu CH, Chao JS. Silicone breast implant with intracapsular rupture coexisting with locally advanced carcinoma. The Breast Journal. 18: 76-7. PMID 22060279 DOI: 10.1111/j.1524-4741.2011.01187.x |
0.57 |
|
2011 |
Tsai CC, Liu HF, Hsu KC, Yang JM, Chen C, Liu KK, Hsu TS, Chao JI. 7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel ROCK inhibitor blocks cytoskeleton function and cell migration. Biochemical Pharmacology. 81: 856-65. PMID 21276421 DOI: 10.1016/j.bcp.2011.01.009 |
0.61 |
|
2010 |
Leung TK, Huang PJ, Lee CM, Chen CS, Wu CH, Chao JS. Can breast magnetic resonance imaging demonstrate characteristic findings of preoperative ductal carcinoma in situ in Taiwanese women? Asian Journal of Surgery / Asian Surgical Association. 33: 143-9. PMID 21163412 DOI: 10.1016/S1015-9584(10)60024-3 |
0.564 |
|
2010 |
Shen B, Gao L, Hsu YT, Bledsoe G, Hagiwara M, Chao L, Chao J. Kallistatin attenuates endothelial apoptosis through inhibition of oxidative stress and activation of Akt-eNOS signaling. American Journal of Physiology. Heart and Circulatory Physiology. 299: H1419-27. PMID 20729399 DOI: 10.1152/Ajpheart.00591.2010 |
0.766 |
|
2010 |
Liu KK, Zheng WW, Wang CC, Chiu YC, Cheng CL, Lo YS, Chen C, Chao JI. Covalent linkage of nanodiamond-paclitaxel for drug delivery and cancer therapy. Nanotechnology. 21: 315106. PMID 20634575 DOI: 10.1088/0957-4484/21/31/315106 |
0.614 |
|
2010 |
Yin H, Gao L, Shen B, Chao L, Chao J. Kallistatin inhibits vascular inflammation by antagonizing tumor necrosis factor-alpha-induced nuclear factor kappaB activation. Hypertension. 56: 260-7. PMID 20566960 DOI: 10.1161/Hypertensionaha.110.152330 |
0.368 |
|
2010 |
Gao L, Smith RS, Chen LM, Chai KX, Chao L, Chao J. Tissue kallikrein promotes prostate cancer cell migration and invasion via a protease-activated receptor-1-dependent signaling pathway. Biological Chemistry. 391: 803-12. PMID 20482314 DOI: 10.1515/Bc.2010.084 |
0.336 |
|
2010 |
Chao J, Shen B, Gao L, Xia CF, Bledsoe G, Chao L. Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing. Biological Chemistry. 391: 345-55. PMID 20180644 DOI: 10.1515/Bc.2010.042 |
0.766 |
|
2010 |
Liu Y, Bledsoe G, Hagiwara M, Yang ZR, Shen B, Chao L, Chao J. Blockade of endogenous tissue kallikrein aggravates renal injury by enhancing oxidative stress and inhibiting matrix degradation. American Journal of Physiology. Renal Physiology. 298: F1033-40. PMID 20089675 DOI: 10.1152/Ajprenal.00518.2009 |
0.779 |
|
2010 |
Shen B, Chao L, Chao J. Pivotal role of JNK-dependent FOXO1 activation in downregulation of kallistatin expression by oxidative stress. American Journal of Physiology. Heart and Circulatory Physiology. 298: H1048-54. PMID 20081110 DOI: 10.1152/Ajpheart.00826.2009 |
0.365 |
|
2010 |
Gao L, Chao L, Chao J. A novel signaling pathway of tissue kallikrein in promoting keratinocyte migration: activation of proteinase-activated receptor 1 and epidermal growth factor receptor. Experimental Cell Research. 316: 376-89. PMID 19879874 DOI: 10.1016/J.Yexcr.2009.10.022 |
0.351 |
|
2009 |
Shen B, Smith RS, Hsu YT, Chao L, Chao J. Kruppel-like factor 4 is a novel mediator of Kallistatin in inhibiting endothelial inflammation via increased endothelial nitric-oxide synthase expression. The Journal of Biological Chemistry. 284: 35471-8. PMID 19858207 DOI: 10.1074/Jbc.M109.046813 |
0.371 |
|
2009 |
Smith RS, Gao L, Bledsoe G, Chao L, Chao J. Intermedin is a new angiogenic growth factor. American Journal of Physiology. Heart and Circulatory Physiology. 297: H1040-7. PMID 19592612 DOI: 10.1152/Ajpheart.00404.2009 |
0.776 |
|
2008 |
Hagiwara M, Bledsoe G, Yang ZR, Smith RS, Chao L, Chao J. Intermedin ameliorates vascular and renal injury by inhibition of oxidative stress. American Journal of Physiology. Renal Physiology. 295: F1735-43. PMID 18829738 DOI: 10.1152/Ajprenal.90427.2008 |
0.792 |
|
2008 |
Chao J, Yin H, Gao L, Hagiwara M, Shen B, Yang ZR, Chao L. Tissue kallikrein elicits cardioprotection by direct kinin b2 receptor activation independent of kinin formation. Hypertension. 52: 715-20. PMID 18768400 DOI: 10.1161/Hypertensionaha.108.114587 |
0.391 |
|
2008 |
Gao L, Yin H, S Smith R, Chao L, Chao J. Role of kallistatin in prevention of cardiac remodeling after chronic myocardial infarction. Laboratory Investigation; a Journal of Technical Methods and Pathology. 88: 1157-66. PMID 18762777 DOI: 10.1038/Labinvest.2008.85 |
0.366 |
|
2008 |
Yao YY, Yin H, Shen B, Smith RS, Liu Y, Gao L, Chao L, Chao J. Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3beta pathway. Cardiovascular Research. 80: 354-64. PMID 18689794 DOI: 10.1093/Cvr/Cvn223 |
0.349 |
|
2008 |
Smith RS, Gao L, Chao L, Chao J. Tissue kallikrein and kinin infusion promotes neovascularization in limb ischemia. Biological Chemistry. 389: 725-30. PMID 18627294 DOI: 10.1515/Bc.2008.084 |
0.41 |
|
2008 |
Hagiwara M, Shen B, Chao L, Chao J. Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation. Human Gene Therapy. 19: 807-19. PMID 18554097 DOI: 10.1089/Hum.2008.016 |
0.442 |
|
2008 |
Shen B, Hagiwara M, Yao YY, Chao L, Chao J. Salutary effect of kallistatin in salt-induced renal injury, inflammation, and fibrosis via antioxidative stress. Hypertension. 51: 1358-65. PMID 18391098 DOI: 10.1161/Hypertensionaha.107.108514 |
0.442 |
|
2008 |
Bledsoe G, Shen B, Yao YY, Hagiwara M, Mizell B, Teuton M, Grass D, Chao L, Chao J. Role of tissue kallikrein in prevention and recovery of gentamicin-induced renal injury. Toxicological Sciences : An Official Journal of the Society of Toxicology. 102: 433-43. PMID 18227104 DOI: 10.1093/Toxsci/Kfn008 |
0.78 |
|
2008 |
Hsu TS, Chen C, Lee PT, Chiu SJ, Liu HF, Tsai CC, Chao JI. 7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway. Cancer Chemotherapy and Pharmacology. 62: 799-808. PMID 18193228 DOI: 10.1007/s00280-007-0667-5 |
0.603 |
|
2008 |
Yin H, Chao L, Chao J. Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusion. Life Sciences. 82: 156-65. PMID 18068196 DOI: 10.1016/J.Lfs.2007.10.021 |
0.379 |
|
2007 |
Yao YY, Yin H, Shen B, Chao L, Chao J. Tissue kallikrein and kinin infusion rescues failing myocardium after myocardial infarction. Journal of Cardiac Failure. 13: 588-96. PMID 17826650 DOI: 10.1016/J.Cardfail.2007.04.009 |
0.343 |
|
2007 |
Yin H, Chao J, Bader M, Chao L. Differential role of kinin B1 and B2 receptors in ischemia-induced apoptosis and ventricular remodeling. Peptides. 28: 1383-9. PMID 17644219 DOI: 10.1016/J.Peptides.2007.05.010 |
0.318 |
|
2007 |
Chao J, Li HJ, Yao YY, Shen B, Gao L, Bledsoe G, Chao L. Kinin infusion prevents renal inflammation, apoptosis, and fibrosis via inhibition of oxidative stress and mitogen-activated protein kinase activity. Hypertension. 49: 490-7. PMID 17224475 DOI: 10.1161/01.Hyp.0000255925.01707.Eb |
0.775 |
|
2007 |
Yao YY, Yin H, Shen B, Chao L, Chao J. Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction. Regulatory Peptides. 140: 12-20. PMID 17196272 DOI: 10.1016/J.Regpep.2006.11.020 |
0.381 |
|
2007 |
Li HJ, Yin H, Yao YY, Shen B, Bader M, Chao L, Chao J. Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation. Cardiovascular Research. 73: 130-42. PMID 17137568 DOI: 10.1016/J.Cardiores.2006.10.014 |
0.315 |
|
2006 |
Chao J, Bledsoe G, Yin H, Chao L. The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction. Biological Chemistry. 387: 665-75. PMID 16800727 DOI: 10.1515/Bc.2006.085 |
0.772 |
|
2006 |
Bledsoe G, Shen B, Yao Y, Zhang JJ, Chao L, Chao J. Reversal of renal fibrosis, inflammation, and glomerular hypertrophy by kallikrein gene delivery. Human Gene Therapy. 17: 545-55. PMID 16716111 DOI: 10.1089/Hum.2006.17.545 |
0.826 |
|
2006 |
Xia CF, Smith RS, Shen B, Yang ZR, Borlongan CV, Chao L, Chao J. Postischemic brain injury is exacerbated in mice lacking the kinin B2 receptor. Hypertension. 47: 752-61. PMID 16534002 DOI: 10.1161/01.Hyp.0000214867.35632.0E |
0.326 |
|
2006 |
Xia CF, Yin H, Yao YY, Borlongan CV, Chao L, Chao J. Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis. Human Gene Therapy. 17: 206-19. PMID 16454654 DOI: 10.1089/Hum.2006.17.206 |
0.395 |
|
2006 |
Bledsoe G, Crickman S, Mao J, Xia CF, Murakami H, Chao L, Chao J. Kallikrein/kinin protects against gentamicin-induced nephrotoxicity by inhibition of inflammation and apoptosis. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 21: 624-33. PMID 16401625 DOI: 10.1093/Ndt/Gfi225 |
0.751 |
|
2006 |
Xia CF, Yin H, Borlongan CV, Chao J, Chao L. Postischemic infusion of adrenomedullin protects against ischemic stroke by inhibiting apoptosis and promoting angiogenesis. Experimental Neurology. 197: 521-30. PMID 16343485 DOI: 10.1016/J.Expneurol.2005.10.027 |
0.357 |
|
2005 |
Hua H, Zhou S, Liu Y, Wang Z, Wan C, Li H, Chen C, Li G, Zeng C, Chen L, Chao L, Chao J. Relationship between the regulatory region polymorphism of human tissue kallikrein gene and essential hypertension. Journal of Human Hypertension. 19: 715-21. PMID 15905889 DOI: 10.1038/sj.jhh.1001875 |
0.614 |
|
2005 |
Xia CF, Bledsoe G, Chao L, Chao J. Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats. American Journal of Physiology. Renal Physiology. 289: F622-31. PMID 15886273 DOI: 10.1152/Ajprenal.00427.2004 |
0.782 |
|
2005 |
Montanari D, Yin H, Dobrzynski E, Agata J, Yoshida H, Chao J, Chao L. Kallikrein gene delivery improves serum glucose and lipid profiles and cardiac function in streptozotocin-induced diabetic rats. Diabetes. 54: 1573-80. PMID 15855348 DOI: 10.2337/Diabetes.54.5.1573 |
0.369 |
|
2005 |
Smith RS, Agata J, Xia CF, Chao L, Chao J. Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction. Life Sciences. 76: 2457-71. PMID 15763077 DOI: 10.1016/J.Lfs.2004.11.028 |
0.422 |
|
2005 |
Chao JH, Sun YC, Chen CJ, Tseng CL, Yang MH. Determination of trace Al in silicon carbide by epithermal neutron activation. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 62: 561-7. PMID 15701410 DOI: 10.1016/j.apradiso.2004.09.007 |
0.56 |
|
2005 |
Chao J, Chao L. Kallikrein-kinin in stroke, cardiovascular and renal disease. Experimental Physiology. 90: 291-8. PMID 15653716 DOI: 10.1113/expphysiol.2004.028464 |
0.355 |
|
2005 |
Yin H, Chao L, Chao J. Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways. The Journal of Biological Chemistry. 280: 8022-30. PMID 15611141 DOI: 10.1074/Jbc.M407179200 |
0.388 |
|
2004 |
Xia CF, Yin H, Borlongan CV, Chao J, Chao L. Adrenomedullin gene delivery protects against cerebral ischemic injury by promoting astrocyte migration and survival. Human Gene Therapy. 15: 1243-54. PMID 15684700 DOI: 10.1089/Hum.2004.15.1243 |
0.416 |
|
2004 |
Zhang JJ, Bledsoe G, Kato K, Chao L, Chao J. Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress. Kidney International. 66: 722-32. PMID 15253727 DOI: 10.1111/J.1523-1755.2004.00794.X |
0.809 |
|
2004 |
Wang T, Li H, Zhao C, Chen C, Li J, Chao J, Chao L, Xiao X, Wang DW. Recombinant adeno-associated virus-mediated kallikrein gene therapy reduces hypertension and attenuates its cardiovascular injuries. Gene Therapy. 11: 1342-50. PMID 15175642 DOI: 10.1038/Sj.Gt.3302294 |
0.72 |
|
2004 |
Chao JC, Tseng HP, Chang CW, Chien YY, Au HK, Chen JR, Chen CF. Chicken extract affects colostrum protein compositions in lactating women. The Journal of Nutritional Biochemistry. 15: 37-44. PMID 14711459 |
0.585 |
|
2004 |
Xia CF, Yin H, Borlongan CV, Chao L, Chao J. Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis. Hypertension. 43: 452-9. PMID 14698996 DOI: 10.1161/01.Hyp.0000110905.29389.E5 |
0.424 |
|
2004 |
Yin H, Chao L, Chao J. Adrenomedullin protects against myocardial apoptosis after ischemia/reperfusion through activation of Akt-GSK signaling. Hypertension. 43: 109-16. PMID 14662648 DOI: 10.1161/01.Hyp.0000103696.60047.55 |
0.377 |
|
2003 |
Zhao C, Wang P, Xiao X, Chao J, Chao L, Wang DW, Zeldin DC. Gene therapy with human tissue kallikrein reduces hypertension and hyperinsulinemia in fructose-induced hypertensive rats. Hypertension. 42: 1026-33. PMID 14568997 DOI: 10.1161/01.Hyp.0000097603.55404.35 |
0.418 |
|
2003 |
Bledsoe G, Chao L, Chao J. Kallikrein gene delivery attenuates cardiac remodeling and promotes neovascularization in spontaneously hypertensive rats. American Journal of Physiology. Heart and Circulatory Physiology. 285: H1479-88. PMID 12816755 DOI: 10.1152/Ajpheart.01129.2002 |
0.768 |
|
2003 |
Miao RQ, Chen V, Chao L, Chao J. Structural elements of kallistatin required for inhibition of angiogenesis. American Journal of Physiology. Cell Physiology. 284: C1604-13. PMID 12734113 DOI: 10.1152/Ajpcell.00524.2002 |
0.721 |
|
2003 |
Agata J, Zhang JJ, Chao J, Chao L. Adrenomedullin gene delivery inhibits neointima formation in rat artery after balloon angioplasty. Regulatory Peptides. 112: 115-20. PMID 12667632 DOI: 10.1016/S0167-0115(03)00029-6 |
0.671 |
|
2003 |
Wang C, Chao J, Chao L. Adenovirus-mediated human prostasin gene delivery is linked to increased aldosterone production and hypertension in rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 284: R1031-6. PMID 12626364 DOI: 10.1152/Ajpregu.00660.2002 |
0.419 |
|
2003 |
Ni A, Yin H, Agata J, Yang Z, Chao L, Chao J. Overexpression of kinin B1 receptors induces hypertensive response to des-Arg9-bradykinin and susceptibility to inflammation. The Journal of Biological Chemistry. 278: 219-25. PMID 12411434 DOI: 10.1074/Jbc.M209490200 |
0.764 |
|
2002 |
Chao J, Chao L. The Role of Adrenomedullin in Cardiovascular and Renal Function. Drug News & Perspectives. 15: 511-518. PMID 12677190 |
0.344 |
|
2002 |
Dobrzynski E, Montanari D, Agata J, Zhu J, Chao J, Chao L. Adrenomedullin improves cardiac function and prevents renal damage in streptozotocin-induced diabetic rats. American Journal of Physiology. Endocrinology and Metabolism. 283: E1291-8. PMID 12424108 DOI: 10.1152/Ajpendo.00147.2002 |
0.404 |
|
2002 |
Agata J, Chao L, Chao J. Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction. Hypertension. 40: 653-9. PMID 12411458 DOI: 10.1161/01.Hyp.0000036035.41122.99 |
0.378 |
|
2002 |
Miao RQ, Agata J, Chao L, Chao J. Kallistatin is a new inhibitor of angiogenesis and tumor growth. Blood. 100: 3245-52. PMID 12384424 DOI: 10.1182/Blood-2002-01-0185 |
0.734 |
|
2002 |
Smith RS, Lin KF, Agata J, Chao L, Chao J. Human endothelial nitric oxide synthase gene delivery promotes angiogenesis in a rat model of hindlimb ischemia. Arteriosclerosis, Thrombosis, and Vascular Biology. 22: 1279-85. PMID 12171788 DOI: 10.1161/01.Atv.0000026613.18742.67 |
0.669 |
|
2002 |
Thongboonkerd V, Gozal E, Sachleben LR, Arthur JM, Pierce WM, Cai J, Chao J, Bader M, Pesquero JB, Gozal D, Klein JB. Proteomic analysis reveals alterations in the renal kallikrein pathway during hypoxia-induced hypertension. The Journal of Biological Chemistry. 277: 34708-16. PMID 12121987 DOI: 10.1074/Jbc.M203799200 |
0.429 |
|
2002 |
Chao J, Wang C, Chao L. Adenovirus-mediated gene transfer for cardiovascular and renal diseases. Methods in Enzymology. 346: 247-63. PMID 11883071 DOI: 10.1016/S0076-6879(02)46059-4 |
0.337 |
|
2002 |
Porcu P, Emanueli C, Kapatsoris M, Chao J, Chao L, Madeddu P. Reversal of angiogenic growth factor upregulation by revascularization of lower limb ischemia. Circulation. 105: 67-72. PMID 11772878 DOI: 10.1161/Hc0102.101360 |
0.331 |
|
2001 |
Chao J, Kato K, Zhang JJ, Dobrzynski E, Wang C, Agata J, Chao L. Human adrenomedullin gene delivery protects against cardiovascular remodeling and renal injury. Peptides. 22: 1731-7. PMID 11754958 DOI: 10.1016/S0196-9781(01)00510-1 |
0.698 |
|
2001 |
Wolf WC, Evans DM, Chao L, Chao J. A synthetic tissue kallikrein inhibitor suppresses cancer cell invasiveness. The American Journal of Pathology. 159: 1797-805. PMID 11696440 DOI: 10.1016/S0002-9440(10)63026-X |
0.784 |
|
2001 |
Emanueli C, Salis MB, Stacca T, Gaspa L, Chao J, Chao L, Piana A, Madeddu P. Rescue of Impaired Angiogenesis in Spontaneously Hypertensive Rats by Intramuscular Human Tissue Kallikrein Gene Transfer Hypertension. 38: 136-141. PMID 11463774 DOI: 10.1161/01.Hyp.38.1.136 |
0.402 |
|
2001 |
Wang C, Dobrzynski E, Chao J, Chao L. Adrenomedullin gene delivery attenuates renal damage and cardiac hypertrophy in Goldblatt hypertensive rats American Journal of Physiology-Renal Physiology. 280. PMID 11352835 DOI: 10.1152/Ajprenal.2001.280.6.F964 |
0.455 |
|
2001 |
Chao J, Miao RQ, Chen V, Chen LM, Chao L. Novel roles of kallistatin, a specific tissue kallikrein inhibitor, in vascular remodeling. Biological Chemistry. 382: 15-21. PMID 11258665 DOI: 10.1515/Bc.2001.003 |
0.765 |
|
2001 |
Chen VC, Chao L, Pimenta DC, Bledsoe G, Juliano L, Chao J. Identification of a major heparin-binding site in kallistatin. The Journal of Biological Chemistry. 276: 1276-84. PMID 11016932 DOI: 10.1074/Jbc.M005791200 |
0.707 |
|
2000 |
Dobrzynski E, Wang C, Chao J, Chao L. Adrenomedullin gene delivery attenuates hypertension, cardiac remodeling, and renal injury in deoxycorticosterone acetate-salt hypertensive rats. Hypertension. 36: 995-1001. PMID 11116114 DOI: 10.1161/01.Hyp.36.6.995 |
0.467 |
|
2000 |
Chen VC, Chao L, Chao J. A positively charged loop on the surface of kallistatin functions to enhance tissue kallikrein inhibition by acting as a secondary binding site for kallikrein. Journal of Biological Chemistry. 275: 40371-40377. PMID 10991942 DOI: 10.1074/Jbc.M005691200 |
0.308 |
|
2000 |
Agata J, Miao RQ, Yayama K, Chao L, Chao J. Bradykinin B(1) receptor mediates inhibition of neointima formation in rat artery after balloon angioplasty. Hypertension. 36: 364-70. PMID 10988266 DOI: 10.1161/01.Hyp.36.3.364 |
0.731 |
|
2000 |
Zhang JJ, Yoshida H, Chao L, Chao J. Human adrenomedullin gene delivery protects against cardiac hypertrophy, fibrosis, and renal damage in hypertensive dahl salt-sensitive rats. Human Gene Therapy. 11: 1817-27. PMID 10986555 DOI: 10.1161/01.Hyp.36.Suppl_1.691-A |
0.693 |
|
2000 |
Wolf WC, Yoshida H, Agata J, Chao L, Chao J. Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure. Kidney International. 58: 730-9. PMID 10916096 DOI: 10.1046/J.1523-1755.2000.00219.X |
0.804 |
|
2000 |
Chen VC, Chao L, Chao J. Reactive-site specificity of human kallistatin toward tissue kallikrein probed by site-directed mutagenesis. Biochimica Et Biophysica Acta. 1479: 237-246. PMID 10862973 DOI: 10.1016/S0167-4838(00)00044-3 |
0.32 |
|
2000 |
Emanueli C, Salis MB, Chao J, Chao L, Agata J, Lin KF, Munaò A, Straino S, Minasi A, Capogrossi MC, Madeddu P. Adenovirus-mediated human tissue kallikrein gene delivery inhibits neointima formation induced by interruption of blood flow in mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 20: 1459-66. PMID 10845858 DOI: 10.1161/01.Atv.20.6.1459 |
0.647 |
|
2000 |
Wang D, Yoshida H, Song Q, Chao L, Chao J. Enhanced renal function in bradykinin B2 receptor transgenic mice American Journal of Physiology-Renal Physiology. 278. PMID 10710553 DOI: 10.1152/Ajprenal.2000.278.3.F484 |
0.358 |
|
2000 |
Miao RQ, Murakami H, Song Q, Chao L, Chao J. Kallistatin stimulates vascular smooth muscle cell proliferation and migration in vitro and neointima formation in balloon-injured rat artery. Circulation Research. 86: 418-24. PMID 10700446 DOI: 10.1161/01.Res.86.4.418 |
0.736 |
|
2000 |
Yoshida H, Zhang JJ, Chao L, Chao J. Kallikrein gene delivery attenuates myocardial infarction and apoptosis after myocardial ischemia and reperfusion. Hypertension. 35: 25-31. PMID 10642270 DOI: 10.1161/01.Hyp.35.1.25 |
0.65 |
|
2000 |
Wang C, Montanari D, Chao L, Chao J. Adenovirus-Mediated Human Kallikrein Gene Delivery Increases Endogenous Rat Tissue Kallikrein in Hypertensive Rat Models Hypertension. 36: 729-729. DOI: 10.1161/01.Hyp.36.Suppl_1.729-C |
0.452 |
|
2000 |
Montanari D, Dobrzynski E, Chao J, Chao L. Human Tissue Kallikrein Gene Delivery Attenuates Cardiac Glycogen Accumulation in Streptozotocin-Induced Diabetic Rats Hypertension. 36: 703-703. DOI: 10.1161/01.Hyp.36.Suppl_1.703-C |
0.366 |
|
2000 |
Madeddu PR, Salis BM, Chao J, Chao L, Costanza E. Human Tissue Kallikrein Gene Transfer Induces Angiogenesis Hypertension. 36: 691-691. DOI: 10.1161/01.Hyp.36.Suppl_1.691-B |
0.361 |
|
2000 |
Emanueli C, Minasi A, Zacheo A, Chao J, Chao L, Salis BM, Madeddu PR, Capogrossi MC. Human Tissue Kallikrein Gene Transfer Accelerates Spontaneous Angiogenesis Response to Ischemia Hypertension. 36: 270-270. DOI: 10.1161/01.Hyp.36.Suppl_1.270-A |
0.398 |
|
1999 |
Chao J, Wang C, Chao L. Gene therapy for hypertension: a review of potential targets. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. 11: 43-53. PMID 18031114 DOI: 10.2165/00063030-199911010-00005 |
0.34 |
|
1999 |
Murakami H, Miao RQ, Chao L, Chao J. Adenovirus-mediated kallikrein gene transfer inhibits neointima formation via increased production of nitric oxide in rat artery. Immunopharmacology. 44: 137-43. PMID 10604537 DOI: 10.1016/S0162-3109(99)00120-4 |
0.755 |
|
1999 |
Dobrzynski E, Yoshida H, Chao J, Chao L. Adenovirus-mediated kallikrein gene delivery attenuates hypertension and protects against renal injury in deoxycorticosterone-salt rats Immunopharmacology. 44: 57-65. PMID 10604525 DOI: 10.1016/S0162-3109(99)00121-6 |
0.449 |
|
1999 |
Madeddu P, Emanueli C, Gaspa L, Salis B, Milia AF, Chao L, Chao J. Role of the bradykinin B2 receptor in the maturation of blood pressure phenotype: lesson from transgenic and knockout mice. Immunopharmacology. 44: 9-13. PMID 10604518 DOI: 10.1016/S0162-3109(99)00105-8 |
0.328 |
|
1999 |
Zhang JJ, Wang C, Lin KF, Chao L, Chao J. Human tissue kallikrein attenuates hypertension and secretes into circulation and urine after intramuscular gene delivery in hypertensive rats. Clinical and Experimental Hypertension (New York, N.Y. : 1993). 21: 1145-60. PMID 10513833 DOI: 10.3109/10641969909052194 |
0.775 |
|
1999 |
Hatcher HC, Wright NM, Chao J, Chao L, Ma JX. Kallikrein-binding protein is induced by growth hormone in the dwarf rat. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 13: 1839-44. PMID 10506588 DOI: 10.1096/Fasebj.13.13.1839 |
0.374 |
|
1999 |
Zhang JJ, Chao L, Chao J. Adenovirus-mediated kallikrein gene delivery reduces aortic thickening and stroke-induced death rate in Dahl salt-sensitive rats. Stroke; a Journal of Cerebral Circulation. 30: 1925-31; discussion . PMID 10471446 DOI: 10.1161/01.Str.30.9.1925 |
0.612 |
|
1999 |
Murakami H, Yayama K, Miao RQ, Wang C, Chao L, Chao J. Kallikrein gene delivery inhibits vascular smooth muscle cell growth and neointima formation in the rat artery after balloon angioplasty. Hypertension. 34: 164-70. PMID 10454435 DOI: 10.1161/01.Hyp.34.2.164 |
0.763 |
|
1999 |
Murakami H, Yayama K, Chao J, Chao L. Atrial natriuretic peptide gene delivery attenuates gentamycin-induced nephrotoxicity in rats. Nephrology Dialysis Transplantation. 14: 1376-1384. PMID 10382996 DOI: 10.1093/Ndt/14.6.1376 |
0.439 |
|
1999 |
Emanueli C, Chao J, Regoli D, Chao L, Ni A, Madeddu P. The bradykinin B1 receptor and the central regulation of blood pressure in spontaneously hypertensive rats. British Journal of Pharmacology. 126: 1769-76. PMID 10372819 DOI: 10.1038/Sj.Bjp.0702527 |
0.744 |
|
1999 |
Jin L, Chao L, Chao J. Potassium supplement upregulates the expression of renal kallikrein and bradykinin B2 receptor in SHR American Journal of Physiology - Renal Physiology. 276. PMID 10070172 DOI: 10.1152/Ajprenal.1999.276.3.F476 |
0.416 |
|
1999 |
Lin KF, Chao J, Chao L. Atrial natriuretic peptide gene delivery reduces stroke-induced mortality rate in Dahl salt-sensitive rats. Hypertension. 33: 219-24. PMID 9931108 DOI: 10.1161/01.Hyp.33.1.219 |
0.678 |
|
1999 |
Wolf WC, Harley RA, Sluce D, Chao L, Chao J. Localization and expression of tissue kallikrein and kallistatin in human blood vessels. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 47: 221-8. PMID 9889257 DOI: 10.1177/002215549904700210 |
0.793 |
|
1998 |
Wolf WC, Harley RA, Sluce D, Chao L, Chao J. Cellular localization of kallistatin and tissue kallikrein in human pancreas and salivary glands. Histochemistry and Cell Biology. 110: 477-84. PMID 9826127 DOI: 10.1007/S004180050309 |
0.787 |
|
1998 |
Ni A, Chai KX, Chao L, Chao J. Molecular cloning and expression of rat bradykinin B1 receptor. Biochimica Et Biophysica Acta. 1442: 177-85. PMID 9804950 DOI: 10.1016/S0167-4781(98)00163-8 |
0.762 |
|
1998 |
Chao J, Zhang JJ, Lin KF, Chao L. Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl salt-sensitive rats. Kidney International. 54: 1250-60. PMID 9767541 DOI: 10.1046/J.1523-1755.1998.00104.X |
0.759 |
|
1998 |
Stadnicki A, Chao J, Stadnicka I, Van Tol E, Lin KF, Li F, Sartor RB, Colman RW. Localization and secretion of tissue kallikrein in peptidoglycan-induced enterocolitis in Lewis rats. The American Journal of Physiology. 275: G854-61. PMID 9756518 |
0.639 |
|
1998 |
Lin KF, Chao J, Chao L. Atrial natriuretic peptide gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in salt-sensitive rats. Human Gene Therapy. 9: 1429-38. PMID 9681414 DOI: 10.1089/Hum.1998.9.10-1429 |
0.698 |
|
1998 |
Yayama K, Wang C, Chao L, Chao J. Kallikrein Gene Delivery Attenuates Hypertension and Cardiac Hypertrophy and Enhances Renal Function in Goldblatt Hypertensive Rats Hypertension. 31: 1104-1110. PMID 9576121 DOI: 10.1161/01.Hyp.31.5.1104 |
0.414 |
|
1998 |
Wang C, Chao C, Madeddu P, Chao L, Chao J. Central Delivery of Human Tissue Kallikrein Gene Reduces Blood Pressure in Hypertensive Rats Biochemical and Biophysical Research Communications. 244: 449-454. PMID 9514899 DOI: 10.1006/Bbrc.1998.8232 |
0.404 |
|
1998 |
Chao J, Zhang JJ, Lin KF, Chao L. Human kallikrein gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in Dahl salt-sensitive rats. Human Gene Therapy. 9: 21-31. PMID 9458239 DOI: 10.1089/Hum.1998.9.1-21 |
0.775 |
|
1998 |
Ni A, Chao L, Chao J. Transcription factor nuclear factor kappaB regulates the inducible expression of the human B1 receptor gene in inflammation. The Journal of Biological Chemistry. 273: 2784-91. PMID 9446586 DOI: 10.1074/Jbc.273.5.2784 |
0.747 |
|
1997 |
Wang C, Ford P, Chao C, Chao L, Chao J. Effect of cyclosporin A on the expression of tissue kallikrein, kininogen, and bradykinin receptor in rat. American Journal of Physiology. Renal Physiology. 273: F783-F789. PMID 29587107 DOI: 10.1152/Ajprenal.1997.273.5.F783 |
0.399 |
|
1997 |
Chao J, Jin L, Lin KF, Chao L. Adrenomedullin gene delivery reduces blood pressure in spontaneously hypertensive rats. Hypertension Research : Official Journal of the Japanese Society of Hypertension. 20: 269-77. PMID 9453262 DOI: 10.1291/Hypres.20.269 |
0.637 |
|
1997 |
Jin L, Zhang JJ, Chao L, Chao J. Gene therapy in hypertension: adenovirus-mediated kallikrein gene delivery in hypertensive rats. Human Gene Therapy. 8: 1753-61. PMID 9358025 DOI: 10.1089/Hum.1997.8.15-1753 |
0.675 |
|
1997 |
Chai KX, Chen VC, Ni A, Lindpaintner K, Rubattu S, Chao L, Chao J. Molecular cloning and expression of rat kallistatin gene. Biochimica Et Biophysica Acta. 1353: 277-86. PMID 9349723 DOI: 10.1016/S0167-4781(97)00100-0 |
0.763 |
|
1997 |
Lin KF, Chao L, Chao J. Prolonged reduction of high blood pressure with human nitric oxide synthase gene delivery. Hypertension. 30: 307-13. PMID 9314409 DOI: 10.1161/01.Hyp.30.3.307 |
0.645 |
|
1997 |
Chao J, Yang Z, Jin L, Lin KF, Chao L. Kallikrein gene therapy in newborn and adult hypertensive rats. Canadian Journal of Physiology and Pharmacology. 75: 750-6. PMID 9276159 DOI: 10.1139/Y97-086 |
0.662 |
|
1997 |
Wang C, Chao C, Chao L, Chao J. Expression of human tissue kallikrein in rat salivary glands and its secretion into circulation following adenovirus-mediated gene transfer Immunopharmacology. 36: 221-227. PMID 9228550 DOI: 10.1016/S0162-3109(97)00025-8 |
0.403 |
|
1997 |
Madeddu P, Varoni MV, Demontis MP, Chao J, Simson JA, Glorioso N, Anania V. Kallikrein-Kinin System and Blood Pressure Sensitivity to Salt Hypertension. 29: 471-477. PMID 9039144 DOI: 10.1161/01.Hyp.29.1.471 |
0.307 |
|
1997 |
Chao JR, Chen CS, Wang TF, Tseng LH, Tsai JJ, Kuo ML, Yen JJ, Yang Yen HF. Characterization of factor-independent variants derived from TF-1 hematopoietic progenitor cells: the role of the Raf/MAP kinase pathway in the anti-apoptotic effect of GM-CSF. Oncogene. 14: 721-8. PMID 9038380 DOI: 10.1038/sj.onc.1200884 |
0.613 |
|
1997 |
Ma JX, Song Q, Hatcher HC, Crouch RK, Chao L, Chao J. Expression and cellular localization of the kallikrein-kinin system in human ocular tissues. Experimental Eye Research. 63: 19-26. PMID 8983960 DOI: 10.1006/Exer.1996.0087 |
0.371 |
|
1996 |
Wang C, Chao C, Chen LM, Chao L, Chao J. High-salt diet upregulates kininogen and downregulates tissue kallikrein expression in Dahl-SS and SHR rats American Journal of Physiology-Renal Physiology. 271. PMID 8898012 DOI: 10.1152/Ajprenal.1996.271.4.F824 |
0.371 |
|
1996 |
Wang DZ, Song Q, Chen LM, Chao L, Chao J. Expression and cellular localization of tissue kallikrein-kinin system in human adrenal gland. American Journal of Physiology-Renal Physiology. 271. PMID 8853434 DOI: 10.1152/Ajprenal.1996.271.3.F709 |
0.348 |
|
1996 |
Chai KX, Ni A, Wang D, Ward DC, Chao J, Chao L. Genomic DNA sequence, expression, and chromosomal localization of the human B1 bradykinin receptor gene BDKRB1. Genomics. 31: 51-7. PMID 8808279 DOI: 10.1006/Geno.1996.0008 |
0.742 |
|
1996 |
Chao C, Madeddu P, Wang C, Liang Y, Chao L, Chao J. Differential regulation of kallikrein, kininogen, and kallikrein-binding protein in arterial hypertensive rats American Journal of Physiology-Renal Physiology. 271. PMID 8760246 DOI: 10.1152/Ajprenal.1996.271.1.F78 |
0.377 |
|
1996 |
Ma JX, Chao J, Chao L. Identification and characterization of two promoters of rat kallikrein-binding protein gene Biochimica Et Biophysica Acta. 1307: 285-293. PMID 8688463 DOI: 10.1016/0167-4781(96)81374-1 |
0.369 |
|
1995 |
Ma J, Yang Z, Chao J, Chao L. Intramuscular delivery of rat kallikrein-binding protein gene reverses hypotension in transgenic mice expressing human tissue kallikrein. Journal of Biological Chemistry. 270: 451-455. PMID 7814410 DOI: 10.1074/Jbc.270.1.451 |
0.377 |
|
1995 |
Chen LM, Richards GP, Chao L, Chao J. Molecular cloning, purification and in situ localization of human colon kallikrein. The Biochemical Journal. 307: 481-6. PMID 7733886 DOI: 10.1042/Bj3070481 |
0.358 |
|
1995 |
Chi KH, Chen CH, Chan WK, Chow KC, Chen SY, Yen SH, Chao JY, Chang CY, Chen KY. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 13: 2620-8. PMID 7595716 DOI: 10.1200/JCO.1995.13.10.2620 |
0.581 |
|
1995 |
Wang C, Chao L, Chao J. Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats Journal of Clinical Investigation. 95: 1710-1716. PMID 7535795 DOI: 10.1172/Jci117847 |
0.426 |
|
1995 |
Lin KF, Chao J, Chao L. Human atrial natriuretic peptide gene delivery reduces blood pressure in hypertensive rats. Hypertension. 26: 847-53. PMID 7490138 DOI: 10.1161/01.Hyp.26.6.847 |
0.642 |
|
1994 |
Wang J, Xiong W, Yang Z, Davis T, Dewey MJ, Chao J, Chao L. Human tissue kallikrein induces hypotension in transgenic mice. Hypertension. 23: 236-43. PMID 7508423 DOI: 10.1161/01.Hyp.23.2.236 |
0.35 |
|
1992 |
Chagas JR, Hirata IY, Juliano MA, Xiong W, Wang C, Chao J, Juliano L, Prado ES. Substrate specificities of tissue kallikrein and T-kininogenase: their possible role in kininogen processing. Biochemistry. 31: 4969-74. PMID 1599922 DOI: 10.1021/Bi00136A008 |
0.313 |
|
1991 |
Wang J, Chao J, Chao L. Purification and characterization of recombinant tissue kallikrein from Escherichia coli and yeast Biochemical Journal. 276: 63-71. PMID 2039483 DOI: 10.1042/Bj2760063 |
0.332 |
|
1991 |
Madeddu P, Glorioso N, Maioli M, Demontis MP, Varoni MV, Anania V, Xiong W, Chai K, Chao J. Regulation of rat renal kallikrein expression by estrogen and progesterone. Journal of Hypertension. 9. DOI: 10.1097/00004872-199112000-00106 |
0.361 |
|
1990 |
Xiong W, Chen L, Woodley-Miller C, Simson JAV, Chao J. Identification, purification, and localization of tissue kallikrein in rat heart. Biochemical Journal. 267: 639-646. PMID 2140256 DOI: 10.1042/Bj2670639 |
0.344 |
|
Show low-probability matches. |